<DOC>
	<DOCNO>NCT00136942</DOCNO>
	<brief_summary>The proportion patient achieve LDL-C target define Swiss cholesterol recommendation ( AGLA-recommendations ) across start dos 10 mg , 20 mg , 40 mg , 80 mg atorvastatin .</brief_summary>
	<brief_title>A Swiss Study With Atorvastatin Hyperlipidemic Patients Measuring LDL-Cholesterol</brief_title>
	<detailed_description />
	<mesh_term>Hyperlipidemias</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>Risk factor diagnosis dyslipidemia accord AGLArecommendations ( see appendix B ) screen LDLC &lt; 6.0 mmol/l Triglyceride level &lt; 5.0 mmol/l . Subjects receive high `` usual maintenance '' dos Lipid Lowering Therapy ( LLT ) screening .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>